Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and death in late-stage studies. Read more at straitstimes.com. Read more at ...

Johnson & Johnson's JNJ.N prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and reduced the ...

Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...

The study, which followed patients for over five ‌years, found that those ⁠who received ⁠the regimen were nine times more ...

Gray-market alternatives to steroids, shipped straight from China, have captured the attention of body-conscious young ...

After decades of study and treatment refinement, urologists and sex therapists, along with their patients, remain flummoxed ...

While TRT is only U.S. Food and Drug Administration (FDA)approved for men with clinically low testosterone levels, marketing ...

In an op-ed, the co-founder of Jones opens up about the unique challenges women face when trying to quit vaping.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every ...

Ariel Messman-Rucker is an Oakland-born journalist who now calls the Pacific Northwest her home. When she’s not writing about politics and queer pop culture, she can be found reading, hiking, or ...

A new study from the nonprofit initiative It’s On Us recommends changes to sex education for boys, to help better prevent sexual assaults when they get to college. “A few years ago, we decided to look ...